50% off Premium Yearly

TSE:LABS
An extractor of oils from cannabis. They have the ability to move beyond CBD and THC extraction, into more of a pharmaceutical oil. They have long term contracts. There is some concern they are charging high premiums for extraction, so their margins may shrink in the future. This is not likely to harm them for the next five year, he thinks. A good cash flow producing stock in this space.
Medipharm Labs Corp is a Canadian stock, trading under the symbol LABS.TO (previously LABS-T on Stockchase) on the Toronto Stock Exchange (LABS-CT). It is usually referred to as TSX:LABS or LABS.TO
In the last year, no analyst issued a Buy, Sell, or Hold rating on LABS.TO (previously LABS-T on Stockchase) on Stockchase. Read the latest expert commentary for Medipharm Labs Corp.
Medipharm Labs Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Medipharm Labs Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Medipharm Labs Corp.
Medipharm Labs Corp is followed by 28 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-12, Medipharm Labs Corp (LABS.TO) stock closed at a price of $0.08.